Medical use, illicit use and diversion of prescription stimulant medication.

Substance Abuse Research Center, University of Michigan, Ann Arbor 48105-2194, USA.
Journal of psychoactive drugs (Impact Factor: 1.1). 04/2006; 38(1):43-56. DOI: 10.1080/02791072.2006.10399827
Source: PubMed

ABSTRACT The objective of this study was to examine the prevalence and factors associated with the illicit use of prescription stimulants and to assess the relationship between the medical and illicit use of prescription stimulants among undergraduate college students. A Web survey was self-administered by a random sample of 9,161 undergraduate students attending a large public midwestern university in the spring of 2003. A total of 8.1% reported lifetime illicit use of prescription stimulants and 5.4% reported past year illicit use. The number of undergraduate students who reported illicit use of prescription stimulants exceeded the number of students who reported medical use of prescription stimulants for ADHD. The leading sources of prescription stimulants for illicit use were friends and peers. Multivariate logistic regression analyses revealed several risk factors for illicit use of prescription stimulants such as being male, White, member of a social fraternity or sorority, Jewish religious affiliation, and lower grade point average. All of these characteristics were also related to medically prescribed use of prescription stimulants. Those who initiated medically prescribed use of prescription stimulants for ADHD in elementary school were generally not at increased risk for illicit use of prescription stimulants or other drugs during college as compared to those who were never prescribed stimulant medication. The present study provides evidence that the illicit use of prescription stimulants is a problem among undergraduate college students, and certain subgroups appear to be at heightened risk.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Texte reçu le 28 juillet 2011 ; accepté le 6 mars 2012 Mots clés : médicaments sur ordonnance ; santé mentale ; méthylphénidate ; avancées biomédicales ; éthique clinique Résumé – Le neuroenhancement est un concept anglo-saxon qui concerne la prise de psychotropes psychostimulants par des sujets sains en dehors d'une indication médicale établie ou d'un contexte festif, afin d'obtenir une amélioration éventuelle du fonctionnement mental et cérébral. En 2009, devant l'augmentation aux États-Unis des demandes de neuroenhancement, l'Association américaine de neurologie a publié des recommandations pratiques déclarant qu'« il est éthiquement acceptable de prescrire des neuroenhancers » si un certain nombre de conditions est respecté. Nous présentons ces conditions éthiques et psychopharmacologiques (« le principe de la courbe en U inversé » des performances cognitives en fonction des taux de catécholamines et « le principe de compromis » de l'amélioration cognitive) à travers un cas clinique de prescription de méthylphénidate chez un étudiant en médecine de 24 ans et sans pathologie, préparant l'examen classant national. Nous discutons ensuite le contexte éthique anglo-saxon dans lequel se situent ces recommandations. Abstract – Neuroenhancement in Healthy Subject? A French Case Study. Neuroenhancement is an anglo-saxon con-cept concerning the use of stimulating psychotropic drugs by healthy subjects, outside any established medical indication or festive setting, to achieve an improvement of their mental functioning. In 2009, because of increasing requests for neu-roenhancement in USA, the American Association of Neurology has published practical recommendations stating that "it is ethically permissible to prescribe medications for neuroenhancement" if a number of conditions is met. We present these ethical and psychopharmacological conditions ("the inverted U-Shape principle" in which cognitive performance is related to catecholamine levels and "the trade-off principle" to cognitive enhancement) through a clinical case of methylphenidate prescription in a healthy 24 years old medical student, preparing for the "examen classant national" (the French national ranking before postgraduate education). We then discuss anglo-saxon ethical context in which these recommendations have been proposed.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A PubMed review was conducted for papers reporting on attention-deficit/hyperactivity disorder (ADHD) in postsecondary students. The review was performed in order to determine the prevalence and symptomatology of ADHD in postsecondary students, to examine its effects on academic achievement, and discuss appropriate management. The prevalence of ADHD symptoms among postsecondary students ranges from 2% to 12%. Students with ADHD have lower grade point averages and are more likely to withdraw from courses, to indulge in risky behaviors, and to have other psychiatric comorbidities than their non-ADHD peers. Ensuring that students with ADHD receive appropriate support requires documented evidence of impairment to academic and day-to-day functioning. In adults with ADHD, stimulants improve concentration and attention, although improved academic productivity remains to be demonstrated. ADHD negatively impacts academic performance in students and increases the likelihood of drug and alcohol problems. Affected students may therefore benefit from disability support services, academic accommodations, and pharmacological treatment.
    Neuropsychiatric Disease and Treatment 01/2014; 10:1781-91. · 2.00 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity that cause functional impairment. Recent research indicates that symptoms persist into adulthood in the majority of cases, with prevalence estimates of approximately 5% in the school age population and 2.5%-4% in the adult population. Although students with ADHD are at greater risk for academic underachievement and psychosocial problems, increasing numbers of students with ADHD are graduating from high school and pursuing higher education. Stimulant medications are considered the first line of pharmacotherapy for individuals with ADHD, including college students. Although preliminary evidence indicates that prescription stimulants are safe and effective for college students with ADHD when used as prescribed, very few controlled studies have been conducted concerning the efficacy of prescription stimulants with college students. In addition, misuse of prescription stimulants has become a serious problem on college campuses across the US and has been recently documented in other countries as well. The purpose of the present systematic review was to investigate the efficacy of prescription stimulants for adolescents and young adults with ADHD and the nonmedical use and misuse of prescription stimulants. Results revealed that both prostimulant and stimulant medications, including lisdexamfetamine dimesylate, methylphenidate, amphetamines, and mixed-amphetamine salts, are effective at reducing ADHD symptoms in adolescents and adults with ADHD. Findings also suggest that individuals with ADHD may have higher rates of stimulant misuse than individuals without the disorder, and characteristics such as sex, race, use of illicit drugs, and academic performance are associated with misuse of stimulant medications. Results also indicate that individuals both with and without ADHD are more likely to misuse short-acting agents than long-acting agents. These findings have implications for intervention, prevention, and future research.
    Psychology Research and Behavior Management 01/2014; 7:223-49.

Full-text (2 Sources)

Available from
May 21, 2014